Biopassport Healthcare/Telehealth Services
Remote Healthcare/Telehealth Services
The third and final phase of launch is BioPassport’s remote healthcare/telehealth service ecosystem. The major component of this phase includes the launching of the test kits for COVID-19, lung cancer, and atopy. Consumers will be able to purchase test kits from BioPassport individually, or through a subscription. Other services that fall under telehealth include digital risk stratification, diagnosis, and daily check ups for patients with chronic illnesses such as neurodegenerative disorders, heart disease, and asthma. The platform also offers counseling services for patients of mental illness. Through the platform, the patient will be able to interact with healthcare professionals remotely. Outcomes of sessions with medical professionals will be inputted into the patient’s DPHR by the medical professional. These services will be offered on a subscription basis.
